Novelis Reports Second Quarter Fiscal Year 2025 Results
ATLANTA, Nov. 6, 2024 /PRNewswire/ — Q2 Fiscal Year 2025 Highlights Net income attributable to our common shareholder of $128 million, down 18% YoY; Net income attributable to our common shareholder excluding special items was $179 million, down 1% YoY Adjusted EBITDA of $462 million, down 5%
New Consulting Firm ‘Axcelture’ launched – Focus on ‘Essential Products and Services’
Jesper K. Pedersen, CEO and founder of Axcelture, sees an opportunity to back medium to large enterprises with consulting- and project services, and supporting other consulting firms with project consulting and advisory. MALMÖ, Sweden, Nov. 6, 2024 /PRNewswire/ — Jesper K. Pedersen, who work
Singapore President Tharman’s Calligraphy Auctioned for S$308,888 on DeeDa to Benefit the Underprivileged
SINGAPORE, Nov. 6, 2024 /PRNewswire/ — On November 2, the Singapore Red Cross Society celebrated its 75th Anniversary Benefit Gala (“the Gala”) at Shangri-La Singapore. Among the charity auction items was a piece of calligraphy by Singaporean President Tharman Shanmugaratnam, title
XTransfer Supports Singapore FinTech Festival 2024, Accelerates Business Development in Southeast Asia
SINGAPORE, Nov. 6, 2024 /PRNewswire/ — XTransfer, the World’s Leading & China’s No.1 B2B Cross-Border Trade Payment Platform, is participating in the Singapore Fintech Festival 2024 at the Singapore Expo for the first time. The company proudly supports the event as one of the G
XTransfer Supports Singapore FinTech Festival 2024
Accelerates Business Development in Southeast Asia SINGAPORE, Nov. 6, 2024 /PRNewswire/ — XTransfer, the World’s Leading & China’s No.1 B2B Cross-Border Trade Payment Platform, is participating in the Singapore Fintech Festival 2024 at the Singapore Expo for the first time. The
Honda Motor Co., Ltd. (HMC:NYSE) announced its consolidated financial results for the fiscal first half year ended September 30, 2024
TOKYO, Nov. 6, 2024 /PRNewswire/ — Honda Motor Co., Ltd. today announced its consolidated financial results for the fiscal first half year ended September 30, 2024. Six Months Ended September 30, 2024 (Apr. – Sep.) Total Profit: Operating Profit 742.6 bil. yen / Operating Margin 6.9% In aut
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year Third quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09 Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1
CGI reports fourth quarter and Fiscal 2024 results
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroom Fourth quarter revenue up 4.4% an
Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Ne
Caris Life Sciences Receives FDA Approval for MI Cancer Seek™ as a Companion Diagnostic (CDx) Test
MI Cancer Seek is the first and only simultaneous Whole Exome and Whole Transcriptome-based assay with CDx indications for adults and pediatric patients IRVING, Texas, Nov. 6, 2024 /PRNewswire/ — Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicin
